460eTiP TELESCOPE: Neoadjuvant phase II study of pembrolizumab, carboplatin, and paclitaxel for stage I triple-negative breast cancer. - Gion, M.; Llombart Cussac, A.; Perez Garcia, J.M.; Blancas López-Barajas, I.; Rea, A.; Fazal Salom, J.; Guerrero, J.A.; Pitrelli Vazquez, N.; Martinez Bueno, A.; Reboredo Rendo, C.; Zamora Adelantado, E.; García Saenz, J.Á.; et al. (Annals of Oncology, 2025)